CD8A and neoplasm: This is schematically depicted in Figure 4, where it is evident how proteasome inhibition directly induces a tumoricidal effect and, at the same time, utilizes the reused tumor microenvironment to decrease immunosuppression, increase antigen presentation, and augment CD8+ T-cell responses.